PAHC
Income statement / Annual
Last year (2024), Phibro Animal Health Corporation's total revenue was $1.02 B,
an increase of 4.07% from the previous year.
In 2024, Phibro Animal Health Corporation's net income was $2.42 M.
See Phibro Animal Health Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$1.02 B
|
$977.89 M
|
$942.30 M
|
$833.40 M
|
$800.40 M
|
$828.00 M
|
$820.00 M
|
$764.30 M
|
$751.50 M
|
$748.59 M
|
| Cost of Revenue |
$705.19 M |
$679.65 M |
$656.90 M |
$562.00 M |
$543.50 M |
$563.40 M |
$553.10 M |
$516.00 M |
$512.50 M |
$512.22 M |
| Gross Profit |
$312.49 M |
$298.24 M |
$285.40 M |
$271.40 M |
$256.90 M |
$264.60 M |
$266.90 M |
$248.30 M |
$239.00 M |
$236.37 M |
| Gross Profit Ratio |
0.31 |
0.3 |
0.3 |
0.33 |
0.32 |
0.32 |
0.33 |
0.32 |
0.32 |
0.32 |
| Research and Development
Expenses |
$29.19 M
|
$24.40 M
|
$20.83 M
|
$17.76 M
|
$13.74 M
|
$12.08 M
|
$10.00 M
|
$9.44 M
|
$11.03 M
|
$9.51 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$220.88 M
|
$226.39 M
|
$206.40 M
|
$196.50 M
|
$187.70 M
|
$181.40 M
|
$168.00 M
|
$150.30 M
|
$153.30 M
|
$148.70 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$260.30 M |
$226.39 M |
$206.40 M |
$196.50 M |
$187.70 M |
$181.40 M |
$168.00 M |
$150.30 M |
$153.30 M |
$148.70 M |
| Cost And Expenses |
$964.36 M |
$906.04 M |
$863.30 M |
$758.50 M |
$731.20 M |
$744.80 M |
$721.10 M |
$666.30 M |
$665.80 M |
$660.92 M |
| Interest Income |
$4.47 M |
$3.36 M |
$816,000.00 |
$838,000.00 |
$1.76 M |
$1.90 M |
$1.69 M |
$1.97 M |
$256,000.00 |
$249,000.00 |
| Interest Expense |
$21.97 M |
$17.95 M |
$11.90 M |
$12.90 M |
$12.90 M |
$11.80 M |
$11.90 M |
$14.90 M |
$16.60 M |
$14.55 M |
| Depreciation &
Amortization |
$36.18 M
|
$34.01 M
|
$32.71 M
|
$31.89 M
|
$32.34 M
|
$27.56 M
|
$26.94 M
|
$26.00 M
|
$23.45 M
|
$21.60 M
|
| EBITDA |
$84.61 M
|
$116.63 M
|
$114.82 M
|
$105.50 M
|
$102.16 M
|
$112.75 M
|
$128.62 M
|
$123.42 M
|
$117.06 M
|
$114.92 M
|
| EBITDA Ratio |
0.08 |
0.11 |
0.08 |
0.09 |
0.09 |
0.1 |
0.12 |
0.13 |
0.11 |
0.15 |
| Operating Income Ratio
|
0.05
|
0.07
|
0.05
|
0.05
|
0.05
|
0.09
|
0.12
|
0.13
|
0.11
|
0.12
|
| Total Other
Income/Expenses Net |
-$42.40 M
|
-$17.78 M
|
-$6.66 M
|
-$8.40 M
|
-$13.68 M
|
-$11.72 M
|
-$10.86 M
|
-$17.39 M
|
-$19.44 M
|
-$8.91 M
|
| Income Before Tax |
$10.92 M |
$54.07 M |
$72.30 M |
$66.50 M |
$55.50 M |
$71.50 M |
$88.10 M |
$80.50 M |
$76.80 M |
$78.76 M |
| Income Before Tax Ratio
|
0.01
|
0.06
|
0.08
|
0.08
|
0.07
|
0.09
|
0.11
|
0.11
|
0.1
|
0.11
|
| Income Tax Expense |
$8.50 M |
$21.47 M |
$23.20 M |
$12.10 M |
$22.00 M |
$16.80 M |
$23.20 M |
$15.90 M |
-$6.00 M |
$18.48 M |
| Net Income |
$2.42 M |
$32.61 M |
$49.18 M |
$54.39 M |
$33.55 M |
$54.70 M |
$64.90 M |
$64.60 M |
$82.70 M |
$60.28 M |
| Net Income Ratio |
0 |
0.03 |
0.05 |
0.07 |
0.04 |
0.07 |
0.08 |
0.08 |
0.11 |
0.08 |
| EPS |
0.0596 |
0.81 |
1.21 |
1.34 |
0.83 |
1.35 |
1.61 |
1.63 |
2.11 |
1.55 |
| EPS Diluted |
0.0596 |
0.81 |
1.21 |
1.34 |
0.83 |
1.35 |
1.61 |
1.61 |
2.07 |
1.51 |
| Weighted Average Shares
Out |
$40.50 M
|
$40.50 M
|
$40.50 M
|
$40.47 M
|
$40.45 M
|
$40.41 M
|
$40.20 M
|
$39.50 M
|
$39.30 M
|
$38.97 M
|
| Weighted Average Shares
Out Diluted |
$40.52 M
|
$40.50 M
|
$40.50 M
|
$40.50 M
|
$40.50 M
|
$40.52 M
|
$40.40 M
|
$40.00 M
|
$40.00 M
|
$39.82 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
